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A putative involvement of the vasculature seems to play a critical role in the pathophysiology of graft-versus-
host disease (GVHD). We aimed to characterize alterations of mesenteric resistance arteries in GVHD in a fully
MHC-mismatched model of BALB/c mice conditioned with total body irradiation that underwent trans-
plantation with bone marrow cells and splenocytes from syngeneic (BALB/c) or allogeneic (C57BL/6) donors.
After 4 weeks, animals were sacriﬁced and mesenteric resistance arteries were studied in a pressurized
myograph. The expression of endothelial (eNOS) and inducible nitric oxide (NO)esynthase (iNOS) was
quantiﬁed and vessel wall ultrastructure was investigated with electron microscopy. The myograph study
revealed an endothelial dysfunction in allogeneic-transplant recipients, whereas endothelium-independent
vasodilation was similar to syngeneic-transplant recipients or untreated controls. The expression of eNOS
was decreased and iNOS increased, possibly contributing to endothelial dysfunction. Additionally, arteries of
allogeneic transplant recipients exhibited a geometry-independent increase in vessels strain. For both ﬁnd-
ings, electron microscopy provided a structural correlate by showing severe damage of the whole vessel wall
in allogeneic-transplant recipient animals. Our study provides further data to prove, and is the ﬁrst to
characterize, functional and structural vascular alterations in the early course after allogeneic transplantation
directly in an ex vivo setting and, therefore, strongly supports the hypothesis of a vascular form of GVHD.
 2014 American Society for Blood and Marrow Transplantation.INTRODUCTION
Allogeneic bonemarrow transplantation (BMT) is the only
curative therapy for a variety of hematological disorders. In
the treatment of malignant diseases, the efﬁcacy of alloge-
neic BMT relies not only on the preceding high-intensity
chemotherapy, but mainly on the response of transplanted
immune cells against leukemic cells or the tumor (graft-
versus-leukemia/tumor). Unfortunately, this positive im-
mune response is closely correlated with graft-versus-host
disease (GVHD), in which the cytotoxic donor T cells affect
healthy recipient tissues, causing organ injuries and resulting
in highmorbidity andmortality. Therefore, GVHD is the main
limitation of allogeneic BMT for a broader and safer clinical
use [1-3].dgments on page 1499.
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14.05.002The vasculature, and especially the endothelium, seems to
play an important role in the development of acute GVHD, as
it forms the ﬁrst frontier between the alloreactive donor cells
and the recipient’s tissue [4]. Because the early course after
BMT is complicated by vascular injury syndromes, such as
transplantation-associated microangiopathy, veno-occlusive
disease, or the capillary-leak syndrome, and in the later
course by atherosclerotic cardiovascular complications, the
existence of a vascular form of GVHD is postulated [5-10].
This hypothesis is supported by histological ﬁndings in skin
samples in acute GVHD [11,12], an increased count of circu-
lating endothelial cells [13], and endothelial cell chimerism
after BMT [14]. Furthermore, an increased expression of
endothelial adhesion molecules [15-20], as well as ele-
vated serum levels of soluble adhesion molecules [21], are
described in GVHD.
However, the incidence of an endothelial dysfunction in
the course of clinical GVHD is, up until now, only supported
indirectly by serum markers of endothelial function in
humans [22-26]. Functional studies, as well as a detailedTransplantation.
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Figure 1. Biometric data of animals during the animal experiment. (A) Com-
parison of body weight between ctrl, alloTx, and synTx animals. Body weight
signiﬁcantly declines after allogeneic transplantation. One-way ANOVA for
repeated measurements: P < .001. Post-hoc testing with Fisher LSD: *P < .001
versus ctrl and synTx; #P < .001 versus alloTx and synTx. (B) Clinical GVHD
score of alloTx and synTx animals. The higher score after allogeneic trans-
plantation indicates severe acute GVHD in these animals. Student t-test:
*P < .05 versus synTx. (C) Comparison of mean blood pressure between ctrls,
alloTx, and synTx animals. Blood pressure signiﬁcantly declines in alloTx an-
imals after transplantation. One-way ANOVA for repeated measurements:
P < .001. Post-hoc testing with Fisher LSD: * < .005 versus alloTx and synTx; #
<.007 versus ctrl and synTx.
P.M. Schmid et al. / Biol Blood Marrow Transplant 20 (2014) 1493e15001494evaluation of vascular remodeling regarding changes in wall
thickness, lumen diameter, and passive mechanical proper-
ties, are lacking.
In our actual study, we aimed to characterize for the ﬁrst
time directly functional and structural alterations of
mesenteric resistance arteries in an animal model of acute
GVHD. Therefore, mesenteric arteries of mice that under-
went allogeneic and syngeneic transplantation as well as
untreated BALB/c were investigated 4 weeks after trans-
plantation in a small vessel myograph for endothelium-
dependent and -independent vasodilatory function, as well
as mechanical properties. This principle is a very welle
accepted method in cardiovascular research to directly
characterize vascular function ex vivo [27]. After functional
characterization, arteries were analyzed by electron micro-
scopy for structural alterations.
MATERIALS AND METHODS
Experimental Bone Marrow Transplantation
Female C57BL/6N (H-2b) and BALB/c (H-2d) mice were purchased from
Charles River Laboratories (Charles River, Sulzbach, Germany) and accli-
matized in our animal facility for at least 1 week before starting the ex-
periments. All animal experiments were approved by the local institutional
animal committee of the University of Regensburg and were performed in
accordancewith German animal protection laws. Micewere between 11 and
12 weeks old at the time of BMT. They were housed in micro-isolator cages
with autoclaved bedding and received autoclaved chow and water. Mice
underwent transplantation as previously described [28]. On the day of BMT,
BALB/c recipient mice received lethal total body irradiationwith a total dose
of 9 Gy, delivered in 1 fraction using a linear accelerator with 150 cGy/
minute. After conditioning, the mice received 2.5  106 bone marrow cells
and 2  106 splenocytes from either syngeneic (BALB/c, n ¼ 5, synTx) or
allogeneic (C57BL/6, n ¼ 9, alloTx) donors. Untreated animals served as
controls to detect possible effects of irradiation and transplantation pro-
cedures (n ¼ 8, ctrl). Four animals that in the alloTx group died between day
6 and day 28 after BMT, whereas all animals that in synTx and ctrl groups
survived the observation period of 4 weeks.
Clinical GVHD scores were assessed weekly by a scoring system incor-
porating 5 clinical parameters: weight loss, posture (hunching), mobility,
fur texture, and skin integrity [29]. Each parameter was graded between
0 and 2 and the cumulative score for each mouse was calculated. Once an
animal reached a cumulative score > 6.0, a weight loss of > 35%, or an
absolute weight of < 13 g, it was sacriﬁced and counted as death due to
transplantation-related mortality [29]. Blood pressure was assessed at week
-1, þ1, and þ3 after transplantation by tail cuff method using an automated
cuff inﬂator-pulse detection system (CODA2 Multi-Channel, Computerized,
EMKA Technologies, Paris, France). In weekþ4, the surviving 8 ctrl, 5 alloTx,
and 5 synTx animals were sacriﬁced and the mesenteric vasculature was
dissected for the preparation of small resistance arteries.
Myograph Study
The myograph study was performed according to well-established pro-
tocols in our laboratory [30,31]. In brief, for each animal, 1 second-order
branch of the superior mesenteric artery was prepared and mounted on a
pressurized myograph (111 P; Danish Myo Technology, Aarhus, Denmark).
Arteries were perfused using oxygenated 37C KREBS solution (95% O2, 5%
CO2) pH 7.4econtaining NaCl (118 mmol/L), KH2PO4 (1.18 mmol/L), KCl
(4.7 mmol/L), MgSO4 (1.18 mmol/L), CaCl2 (2.5 mmol/L), D-Glucose
(5.5mmol/L), NaHCO3 (25mmol/L), and EDTA (.026mmol/L). First, studies to
characterize the active vasodilatory properties of the vessels were per-
formed. After precontraction with norepinephrine (NE, 105 mol/L),
endothelium-dependent vasodilationwas assessedwith acetylcholine (ACh)
(1010-104 mol/L) and endothelium-independent vasodilation with the
direct NO donor sodium nitroprusside (SNP) (10-9-102 mol/L). For that
purpose, at each concentration of the given agent, the vessels lumen diam-
eter was determined after 5 minutes of incubation. Thereafter, vessels were
equilibrated at a constant pressure of 45 mmHg, their media thickness and
lumen diameter were measured, and parameters of vessel geometry were
calculated (media/lumen ratio, cross-sectional area [CSA]). Then, myogenic
tonewas inactivated by calciumdepletion through incubationwith Ca2þ-free
KREBS solution for 30 minutes. Intravascular pressure was raised from 3 to
10, 20, 30, and 40 mmHg, and then in 20 mmHg steps up to 140 mmHg, to
assess passive mechanical properties (circumferential strain and stress). At
each step, the pressure was maintained until a steady-state diameter was
reached and changes in internal diameter and media thickness of vesselswere assessed. All vessel measurements for vasodilatory and mechanical
properties were performed at 3 points along the vessel with the use of a
calibrated video system and the mean was calculated. Finally, vessels were
prepared for electron microscopy.
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Figure 2. Endothelium-dependent vasodilatory response of mesenteric
resistance arteries to increasing concentrations of acetylcholine (Ach). Vaso-
dilatory response to ACh is diminished after allogeneic transplantation indi-
cating endothelial dysfunction. Two-way ANOVA for repeated measurements:
P < .001. Post-hoc testing with Holm-Sidak: *P < .0001 versus ctrl and synTx,
#P < .001 versus ctrl and P ¼ .003 versus synTx, xP < .001 versus ctrl and
P ¼ .031 versus synTx.
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The expression of endothelial (eNOS) and inducible nitric oxide (NO)e
synthase (iNOS) in the small arteries wasmeasured using a real-time RT-PCR
as described previously [31]. In brief, mesenteric arteries of the second
branch were collected and total RNA was extracted using RNeasy kit
(Quiagen, Hilden, Germany), according to the instructions of the manufac-
turer. For ﬁrst-strand cDNA synthesis, 1 mg total RNAwas reverse transcribed
with 1U MMLV Reverse Transcriptase, 1 mg Random Primer, 1 mM deoxy-
nucleotide triphosphate mixture, 1 mL recombinant RNasin ribonuclease
inhibitor, and transcription buffer with 5 mM MgCl2 in a ﬁnal volume of
10 mL (all from Promega, Mannheim, Germany). The reaction mixture was
incubated at 37C for 60 minutes, followed by heat inactivation of the
enzyme at 95C for 5 minutes. After cooling on ice for 5 minutes, the cDNA
was stored at 20C. In parallel, 1 mg total RNA was processed without
reverse transcription to control for contamination with genomic DNA. Real-
time RT-PCR detection of eNOS and iNOS was carried out using the ABIPrism
7900 TaqMan (Applied Biosystems, Foster City, CA). Beta-actin was used as
housekeeping gene for normalization. Designed primers for beta-actin,
eNOS, and iNOS were purchased from MWG Operon (Ebersberg, Ger-
many). For each animal, measurements were carried out in triplicates and
the mean was calculated.
Electron Microscopy
As described previously [32], vascular samples were ﬁxed in buffered
Karnovsky solution, postﬁxed in 1% osmium tetroxide, dehydrated in graded
ethanols, and embedded in the EmBed-812 epoxy resin (all reagents from
Science Services, Munich, Germany). Semithin (.8 mm) sections were cut and
stained with toluidine blue/basic fuchsin. The whole vessel circumference
was screened, areas of interest were selected, and the resin block was
trimmed for further sectioning. Ultrathin (80 nm) sections were cut with a
diamond knife on a Reichert Ultracut-S ultramicrotome (Leica, Vienna,
Austria) and double contrasted with aqueous 2% uranyl acetate and lead
citrate solutions. The sections were examined with a LEO912AB trans-
mission electron microscope (Zeiss, Oberkochen, Germany) operating at
80 kilovolt in zero-loss mode. Images were documented (TIFF-format, cali-
brated for distance measurements) with a side-entry mounted 2000 2000
pixel digital camera. The electron microscopic examination included sec-
tions from 3 ctrl, 4 alloTx, and 3 synTx animals.
Data Analysis
For all biometric animal data (Figure 1) and property data (Table 1) of
mesenteric arteries, means of every measurement for ctrl, alloTx, and synTx
animals were calculated. Groups were compared using 1-way ANOVA
(Fisher LSD as post-hoc test) or Student t-test as appropriate. The vessel
vasodilation (Figures 2, 3) was calculated as percentage after a maximal
precontraction with 105 mol/L norepinephrine using the following for-
mula: vasodilation (%) ¼ (dx-dNE)/(dR-dNE)  100. Thereby, dx is the actual
measured diameter at a given concentration of ACh or SNP. dNE is the
diameter under precontraction with norepinephrine, and dR is the resting
diameter of the vessel. The curves created from these calculations were
compared using 2-way ANOVA for repeated measurements with Holm-
Sidak method as post-hoc test. The CSA of the media was calculated as
(p/4)(de2-di2) with de as external vessel diameter and di as lumen diameter of
the vessel at 45 mmHg intraluminal pressure (Table 1). Circumferential
strain (Figure 4) was calculated as ε ¼ (di-d0)/d0, where di was the observed
lumen diameter at a given intraluminal pressure and d0 was the original
diameter measured at 3 mmHg, respectively. Circumferential stress
(Figure 5) was calculated as s¼ (pdi)/(2m) according to Laplace’s lawwith p
being the intraluminal pressure, di the luminal diameter, and m the media
thickness. Strain and stress of the different groups were compared using
2-way ANOVA for repeated measurements (Holm-Sidak method as post-hoc
test). The strain/stress relation (Figure 6) was ﬁtted to an exponential curve
(equation: f[x] ¼ aebx) for each vessel, with b as the slope of each single
curve. The means of every calculated slope for each group were compared
with ANOVA on rank (Dunn’s method as post-hoc test). One-way ANOVA
(Fisher LSD as post-hoc test) was used to analyze eNOS expression andTable 1
Geometry of Mesenteric Arteries at 45 mmHg of Intraluminal Pressure
Parameters Ctrl
(n ¼ 8)
AlloTx
(n ¼ 5)
SynTx
(n ¼ 5)
P
Value*
Media thickness, mm 11.0  .2 10.5  .1 11.2  .6 .37
Lumen diameter, mm 197.0  7.4 217.7  17.1 221.8  18.4 .35
Media/lumen ratio 5.6  .2 4.9  .4 5.1  .3 .26
CSA, mm2 7174  293 7538  598 8320  1007 .41
* P values for 1-way ANOVA.ANOVA on Rank (Dunn’s method as post-hoc test) for iNOS expression
(Figure 7). All data are shown as mean  SEM. A P value of < .05 was
considered as signiﬁcant.RESULTS
Body Weight, Clinical GVHD Score, and Blood Pressure
Figure 1 depicts the biometric animal data during the
course of the animal experiment. At the beginning of the
experiment, mice in each group weighed about 20 g. In ctrl
animals, body weight slightly increased during the following
weeks. In the ﬁrst week after BMT, body weight clearly
declined in both groups and recovered only in the syngeneic
group, up to the level of control animals, until week þ4.
AlloTx animals, however, failed to recover body weight,
resulting in a signiﬁcant lowerweight than in the control and
synTx group inweekþ4. As expected, alloTx animals showed
clinical signs of acute GVHD, objectiﬁed by the GVHD score.
In contrast, synTx animals had no signs of GVHD inweek þ4.
Systolic, diastolic, and mean blood pressure were similar in
all groups at the start of the experiment and were stable inLog Concentration of Sodium Nitroprusside
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Figure 3. Endothelium-independent vasodilatory response of mesenteric
resistance arteries to increasing concentrations of sodium nitroprusside.
Vasodilatory response to sodium nitroprusside is unaffected after allogeneic or
syngeneic transplantation. Two-way ANOVA for repeated measurements:
P ¼ .33.
Strain
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6
S
tre
ss
0,0
0,5
1,0
1,5
2,0
2,5
3,0
3,5
Ctrl (n=8)
AlloTx (n=5)
SynTx (n=5)
*
Figure 6. Strain/stress relationship as mechanical property of mesenteric
arteries. Vessels after allogeneic transplantation show a right shift of their
strain/stress relationship as an expression of an increased compliance at the
same wall tension. Slope of strain/stress relation: ctrl 5.4  .7, alloTx 3.4  .03,
and synTx 5.7  .9. ANOVA on rank P ¼ .007. Post-hoc testing with Dunn’s
method: *P < .05 for alloTx versus ctrl and synTx.
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Figure 4. Strain as passive mechanical property of mesenteric arteries. Vessels
exhibit a signiﬁcant increased strain after allogeneic transplantation. Two-way
ANOVA for repeated measurements: P < .001. Post-hoc testing with Holm-
Sidak: *P < .05 versus ctrl and synTx; #P < .05 versus synTx.
P.M. Schmid et al. / Biol Blood Marrow Transplant 20 (2014) 1493e15001496the ctrl group during the whole experiment. In the week
after transplantation, blood pressure declined but soon
regained the initial level in the synTx group. However, in the
alloTx group, blood pressure did not rise again, resulting in
signiﬁcant lower systolic, diastolic, and mean blood pressure
measurements in week þ3 (Figure 1C exemplarily shows
mean arterial blood pressure).
Vasodilatory Vessel Properties
We tested the vasodilatory response of mesenteric resis-
tance arteries to increasing concentrations of ACh after a
precontraction with norepinephrine (Figure 2). ACh stimu-
lates the production of NO in endothelial cells, which leads to
a relaxation of smooth muscle cells and, therefore, causes an
endothelium-dependent vasodilation.We found signiﬁcantly
decreased vasodilation to ACh only in alloTx animals, indi-
cating endothelial dysfunction after allogeneic BMT. In synTx
animals, endothelial function did not differ signiﬁcantly from
the ctrl group. Maximum vasodilation reached at 104 mol/L
of ACh was 49.7%  8.4%, 85.3  2.9%, and 96.1  2.4% in
the alloTx, synTx, and ctrl group, respectively. Further, weIntraluminal Pressure [mmHg]
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Figure 5. Stress as passive mechanical property of mesenteric arteries. Vessels
stress is unchanged after allogeneic or syngeneic transplantation. Two-way
ANOVA for repeated measurements: P ¼ .91.examined the vasodilatory response to increasing concen-
trations of SNP after precontraction with norepinephrine
(Figure 3). SNP is a direct NO donor, so the observed vasodi-
lation depends only on smooth muscle cell function and not
on endothelial function. Here, we found no differences
between all investigated animal groups.Morphological and Mechanical Vessel Properties
Table 1 shows the morphological data of the mesenteric
arteries in the 3 investigated groups at 45 mmHg of intra-
luminal pressure. We could not detect any signiﬁcant dif-
ferences regarding media thickness, lumen diameter, media/
lumen ratio, and CSA of the media. Circumferential strain
(Figure 4) complies with the relative gain of lumen diameter
with every increase in intraluminal pressure and, therefore,
represents a measure of vessel compliance. The mesenteric
arteries of alloTxmice showed a signiﬁcantly increased strainCtrl AlloTx SynTx Ctrl AlloTx SynTx 
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Figure 7. Relative expression of endothelial NO-synthase (eNOS) and induc-
ible NO-synthase (iNOS) in mesenteric arteries. Expression of eNOS is
decreased and iNOS is increased after allogeneic transplantation. N ¼ 8 for ctrl,
n ¼ 5 for alloTx and synTx. One-way ANOVA for eNOS: P ¼ .003. Post-hoc
testing with Fisher LSD: *P ¼ .003 versus ctrl. and P ¼ .002 versus synTx.
ANOVA on Rank for iNOS: P ¼ .015. Post-hoc testing with Dunn’s method:
#P < .05 versus ctrl.
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vessels of alloTx animals were more distensible compared
with ctrl and synTx animals. Circumferential stress (Figure 5)
matches with the wall tension of vessels and was not
signiﬁcantly different between the different groups. This
indicates that the higher vessel compliance in alloTx animals
is independent of vessel geometry. This is further highlighted
by the strain/stress relationship, which is depicted in
Figure 6. The rightwards shift of the curve of alloTx animals
indicates a higher distensibility, independent of vessel ge-
ometry, with a higher vessel strain at the same given stress.
Accordingly, the comparison between the slopes of the
strain/stress curves of each single vessel showed a signiﬁ-
cantly ﬂatter curve for allogeneic recipients.
Expression of eNOS and iNOS
Figure 7 depicts the expression of eNOS and iNOS in the
mesenteric arteries at mRNA level. ENOS expression in ves-
sels of alloTx mice was signiﬁcantly decreased in comparison
with the ctrl and synTx groups. In contrast, iNOS expression
was signiﬁcantly upregulated compared with untreated
animals.
Structural Vessel Changes
Electron microscopy was performed to reveal possible
structural alterations after allogeneic BMT, which assert the
observed changes in endothelial function and mechanical
properties of the mesenteric arteries. The analysis in the
control group illustrated, as expected, a normal vessel
structure consisting of a plain endothelial cell layer at the
luminal surface followed by the internal elastic lamina
(tunica intima). The tunica media consists mainly of the
smooth muscle cells and is outward bordered from the
tunica adventitia by the lamina elastica externa. The inves-
tigation of the synTx group only showed discrete alterations
compared with untreated animals. These changes affected
the endothelial cells, where we could ﬁnd an edema at some
slices (not shown). However, after allogeneic transplantation,
we could reveal very severe damage of all vessel layers
(Figure 8). We found a perivascular accumulation of inﬂam-
matory cells in the tunica adventitia. Smooth muscle cells
were degenerated and the tunica media showed localized
liquid accumulations. The most severe damage was suffered
in the endothelium. In large parts, endothelial cells were
destroyed and detached from the lamina elastic interna. This
resulted in great gaps between intact endothelial cells and a
largely uncovered lamina elastica interna. In other parts,
endothelial cells were edematous or had an increased pino-
cytotic activity. Furthermore, the lamina elastica interna and
externa also had impressive abnormalities. Both layers could
partly no longer be demarcated, as both were bulked or
totally disintegrated.
DISCUSSION
To our knowledge, the present study is the ﬁrst to
describe, in detail, an involvement of mesenteric resistance
arteries in an animal model of severe acute GVHD. As such,
we proved the presence of endothelial dysfunction and
increased vessel compliance after allogeneic BMT. These
functional data correlate with a dysregulation of eNOS and
iNOS at the mRNA level, as well as severe structural damages
of the vessel wall, as visualized by electron microscopy.
Therefore, our study further substantiates the hypothesis of a
vascular form of GVHD.Endothelial Dysfunction in GVHD
Our study was based on the investigation of functional
properties of mesenteric resistance arteries in a pressurized
myograph. This is an accepted and very well-established
method in cardiovascular research [27]. We observed
endothelium-dependent vasodilation in response to ACh,
which was signiﬁcantly reduced only in alloTx animals
(Figure 2). At the same time, synTx animals did not exhibit
endothelial dysfunction in comparison with untreated ani-
mals. Endothelium-independent vasodilation tested by the
direct NO-donor SNP was unaffected after allogeneic or
syngeneic transplantation, indicating a normal function of
smooth muscle cells (Figure 3). Further, we analyzed the
expression of eNOS and iNOS in the samemesenteric arteries.
ENOS is mainly expressed in endothelial cells and activated
by shear stress. It produces NO in a pulsatile calcium-
dependent manner and has vasoprotective and antiathero-
sclerotic effects. ENOS-derived NO activates soluble guanylyl
cyclase in smooth muscle cells and leads to vasodilation. In
this context, endothelial dysfunction is characterized by the
inability to produce adequate amounts of bioactive NO,
which, among other factors, can be caused by a decreased
expression of eNOS or eNOS uncoupling [33,34]. INOS can be
activated inmacrophages andmany other cells in response to
different inﬂammatory stimuli and produces a huge amount
of NO calcium-independent. INOS-derived NO itself or per-
oxynitrite (formation of NO with O2- ) are cytotoxic, not only
for microbes and tumor cells, but also for healthy tissue, and
can contribute to eNOS uncoupling and endothelial
dysfunction [33,34]. Therefore, the downregulation of eNOS
and upregulation of iNOS in the mesenteric arteries after
allogeneic BMT (Figure 7) is able to explain endothelial
dysfunction. The ﬁnding of increased iNOS activity is fur-
ther substantiated by several studies showing excessively
elevated NO levels in intestinal GVHD [35-41], whereas no
data are available so far about eNOS expression in arteries of
recipients with or without GVHD after allogeneic BMT. Up
until now, endothelial dysfunction was only suggested indi-
rectly by serummarkers of endothelial function [22-26]. This
makes our study the ﬁrst to directly prove endothelial
dysfunction, deﬁned as a decreased vasodilatory response to
ACh in GVHD.
Increased Vessel Compliance in GVHD
Further, we investigated mechanical vessel properties
under no-ﬂow conditions in the myograph. Thereby, possible
ﬂow-mediated changes in vessel diameters or the release of
vasodilatory mediators like NO by shear stress can be mostly
excluded. Besides, the vessels’ own myogenic tone was
inactivated by calcium depletion so that the observed
changes in lumen diameter and wall thickness with
increasing intraluminal pressure almost solely reﬂect passive
vessel mechanics. Our ﬁnding of a greater gain of the vessel
diameters with the stepwise increase of intraluminal pres-
sure in alloTx animals with GVHD compared with synTx and
ctrl animals means that the circumferential wall strain of
vessels with GVHD is more pronounced (Figure 4). This is
equivalent to a reduced arterial stiffness or increased vessel
distensibility in GVHD. Such changes in passive mechanical
vessel properties can be caused by geometry-dependent and
-independent factors [42]. Because we could not ﬁnd any
sign for vascular remodeling or hypertrophy as ascertained
by media thickness, lumen diameter, media/lumen ratio, and
CSA of the media (Table 1), geometry-dependent alterations
do not seem to be causative for the increased distensibility.
Figure 8. Electron microscopy of mesenteric arteries from ctrl and synTx animals in the left column and alloTx animals in the right column. (A) Normal vessel wall in
untreated animals with an intact endothelial cell layer (EC), lamina elastica interna (LEI), tunica media (TM), lamina elastica externa (LEE) and tunica adventitia (TA).
Original magniﬁcation  10,000. In comparison, severe vessel wall damage in alloTx mice is shown. Endothelial cells are destroyed or detached from the LEI (/).
Smooth muscle cells are degenerative, TM shows liquid accumulation (*). Original magniﬁcation  5000. (B) SynTx animals show also a normal vessel wall with an
intact EC and LEE. Original magniﬁcation  10,000. In contrast, LEE is dissolved (/) and the LEI is uncovered (*) in alloTx mice. Original magniﬁcation  5000. (C)
Arteries of synTx animals show an intact LEI. Original magniﬁcation  20,000. LEI is bulked (/) and endothelial cells are edematous (*) in alloTx mice. Original
magniﬁcation  20,000. (D) In synTx animals, no inﬂammatory cells can be found in the tunica adventitia. Original magniﬁcation  5000. In contrast, perivascular
accumulation of inﬂammatory cells in alloTx mice (/). Furthermore, the endothelium shows severe damage (detached endothelium *) and the lamina elastic externa
is not deﬁnable over a distinct range (#). Original magniﬁcation  1600. (E) Some endothelial cells in synTx animals show edema (/). Original
magniﬁcation  20,000. Intact endothelial cells in alloTx mice exhibit an increased pinocytotic activity (/). Original magniﬁcation  20,000.
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tension in the 3 groups (Figure 5). In fact, the right shift of the
strain/stress relationship clearly indicates geometry-
independent reasons for the increased arterial compliance,
because this means that at a given wall tension, the strain of
the vessels in alloTx mice was signiﬁcantly increased
(Figure 6).
To our knowledge, our present study is the ﬁrst to study
directly the mechanical properties of mesenteric resistance
arteries in acute GVHD. In chronic GVHD, a study in humans
evaluated the compliance of the aorta via ultrasound [43]. In
contrast to our study, they found an increased arterial stiff-
ness in patients with disease duration of about 15 months.
Arterial stiffness is an independent risk factor forcardiovascular events [44-47] and associated with different
inﬂammatory diseases [48]. In this context, it is not surpris-
ing that in chronic GVHD, which is characterized by a chronic
inﬂammatory process [49], arterial stiffness develops. How-
ever, the ﬁnding of reduced arterial stiffness in acute GVHD
is new. So far, an increase in arterial compliance is, to our
knowledge, only described in liver cirrhosis, where a hyper-
dynamic splanchnic circulation predominates [32,50-53].
Similarly, increased intestinal blood ﬂow in the superior
mesenteric artery and the bowel wall was detected in pa-
tients with acute GVHD by ultrasound [54]. This matches our
ﬁndings, as the intestinal blood ﬂow is regulated by the tone
of the mesenteric resistance arteries. We see the decreased
arterial blood pressure observed in patients as the clinical
P.M. Schmid et al. / Biol Blood Marrow Transplant 20 (2014) 1493e1500 1499correlate of the increased arterial compliance detected in our
animals (Figure 1).
Structural Vessel Changes in GVHD
One of themainstays of our study is that we could analyze
the same arteries, from which we gathered the functional
data in the myograph, for structural changes with electron
microscopy. As far aswe know, this has never been done in an
animal model of GVHD before. Although vessels after syn-
geneic transplantation only showed discrete changes, such
as endothelial cell edema, arteries after allogeneic trans-
plantation exhibited very severe structural damage affecting
the whole vessel wall. This is of interest because, so far, only
an endothelium involvement was suggested in GVHD
[5,9,10]. Besides, we could correlate all functional alterations
in GVHD with structural ﬁndings. The endothelial dysfunc-
tion is very well explained by the destroyed and detached
endothelium. Even the reduced expression of eNOS can be
explained by the fewer endothelial cells as main source of
eNOS expression. The exact mechanism of endothelial cell
death remains unclear in our study. Some cells exhibit elec-
tron microscopic signs of apoptosis comparable with those
described by Sho et al. [55], but in some others, necrosis is
probable. As discussed below, we would expect apoptosis as
the main mechanism, but necrosis induced by concomitant
infections will certainly contribute to cell death in GVHD.
However, further studies addressing the endothelial cell
death in GVHD need to be done. As a correlate for the
increased vessel compliance, we found bulked lamina elas-
tica interna and externa, as well as the edema of the tunica
media. As a source of the increased expression of iNOS, we
considered the accumulation of inﬂammatory cells in the
tunica adventitia. However, the described damage of smooth
muscle cells seems not to be relevant, as the endothelium-
independent vasodilation was not affected in GVHD.
Role of GVHD
In our study, allogeneic and syngeneic BMT were per-
formed under the same conditions, including total body
irradiation with 9 Gy and infusion of 2.5  106 bone marrow
cells and 2  106 splenocytes. Of notice, animals received
no conditioning chemotherapy. As anticipated, only alloTx
mice developed a severe acute form of GVHD, which was
conﬁrmed by the clinical GVHD score and a continuous
weight loss (Figure 1). This means that the observed func-
tional and structural alterations in mesenteric arteries must
be caused solely by GVHD and are independent of the irra-
diation, the transplantation procedure itself, or, in humans,
usual conditioning chemotherapy. The pathophysiology of
GVHD is characterized by a complex orchestra of different
cellular effectors (mainly cytotoxic T lymphocytes and nat-
ural killer cells) and diverse cytokines (such as interferon g,
TNF, and NO) and ﬁnally results in apoptotic target tissue
destruction [2]. Importantly, GVHD can cause endothelial cell
apoptosis in different manners. It is known that T cells are
able to induce endothelial apoptosis by the perforin/gran-
zyme exocytosis and Fas/Fas ligand death pathway [56]. Also,
interferon g and TNF are able to destroy endothelial cells
[57-62], an effect that is partly mediated by NO [63], which
has, in high concentrations, cytotoxic effects [33,34]. There-
fore, we hypothesize that the increased iNOS expression in
our study in allogeneic transplanterecipient mice (Figure 7)
is, among others, responsible for endothelial cell damage. In
this context, therapeutic or prophylactic approaches to
inhibit iNOS may be promising. However, the exactmechanisms underlying the vascular damage need to be
further investigated.
CONCLUSION
In conclusion, our study provides further data to prove,
and is the ﬁrst to characterize, the involvement of the
vasculature in GVHD. Our electron microscopic analysis of
mesenteric arteries revealed severe damage of the whole
vessel wall after allogeneic BMT. This correlates with func-
tional alterations of the vessels in terms of endothelial
dysfunction, which may be caused by a dysregulation of NO-
synthases, and an increased compliance. Taken together, our
study strongly supports the hypothesis of a self-contained
vascular form of GVHD. Because endothelial dysfunction
and mechanical vessel properties can also be measured
noninvasively in humans by ﬂow-mediated vasodilation and
pulse-wave velocity, it would be of great interest if these
results can be replicated in patients with GVHD. Further
studies to understand the underlyingmechanisms, especially
for endothelial cell death, are now needed. As the contribu-
tion of vascular damage to tissue damage in GVHD seems
possible, endothelium-protective treatments may be used to
ameliorate systemic GVHD.
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